Greater China rights to develop and commercialize telitacicept, a novel, dual-target recombinant fusion protein in global ...

The National Institute for Health and Care Excellence (NICE) recommended the drug not be used by the NHS due to its ...

Although it did not meet the primary endpoint of dose-response relationship, when compared to placebo, enpatoran demonstrated improvements in measures of both systemic and cutaneous disease activity ...

NEW HAVEN, Conn. (WTNH) — In today’s Health Headlines, June is Myasthenia Gravis Awareness Month. What is myasthenia gravis, how is it diagnosed, and what treatments are available? Dr. Kunal … ...

Abstract. Background Comorbid autoimmune disorders affect approximately 0.2% of the population.A second autoimmune disease occurs in up to 15% of myasthenia gravis (MG) patients. Objective To evaluate ...

Exercise-related acute cardiovascular events and potential deleterious adaptations following long-term exercise training: placing the risks into perspective-an update: a scientific statement from the ...

You’ve got to be careful not to bite off more than you can chew, which is a lesson Los Angeles Rams linebacker Jared Verse learned the hard way after testing team legend Aaron Donald recently.

The Food and Drug Administration (FDA) has approved Imaavy ™ (nipocalimab-aahu) for the treatment of generalized myasthenia gravis (gMG) in adult and pediatric patients aged 12 years and older ...

To assess the comparative benefits and harms of immunomodulators and immunosuppressants for people with generalised myasthenia gravis through a network meta-analysis. Secondary To estimate the ...

Fueled by social media, more boys and men are turning to supplements like amino acids, creatine monohydrate, pre-workout drinks or powders, protein bars and whey protein product in an effort to bulk ...

Concluding a recent interview with Jonathan Strober, MD, an investigator on the phase 2/3 Vibrance-MG study (NCT05265273) exploring pediatric use of nipocalimab for generalized myasthenia gravis ...